PO-1096 Safety of concurrent TDM-1 and radiotherapy for patients with residual HER2-positive breast cancer. (August 2021)

• Record Type: Journal Article
• Authors: Becherini, C.; Stocchi, G.; Visani, L.; De Santis, M.C.; Colciago, R.R.; Pedretti, S.; Magrini, S.M.; Nuzzo, M.; Genovesi, D.; Ursini, L.A.; Bonanni, A.; Ippolito, E.; Ramella, S.; De Renzi, F.; Fontana, A.; Vitucci, P.; Angelini, L.; Orsatti, C.; Desideri, I.; Scotti, V.; Orzalesi, L.; Bernini, M.; Sanchez, L.; Nori, J.; Bianchi, S.; Meattini, I.; Livi, L.
• Is Part Of: Radiotherapy and oncology. Volume 161(2021)supplement
• Page Start: S912
• Page End: S913
• Publication Date: 2021-08
• Subjects: Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/S0167-8140(21)07547-2
• Languages: English
• ISSNs: 0167-8140